Naltrexone-HCl ( DrugBank: Naltrexone )


1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00663117
(ClinicalTrials.gov)
September 200618/4/2008The Effects of Naltrexone on Active Crohn's DiseaseThe Effects of Naltrexone in Active Crohn's DiseaseInflammation;Crohn's DiseaseDrug: Naltrexone-HCl;Drug: PlaceboMilton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);The Broad FoundationCompleted18 Years75 YearsAll40Phase 2United States